ÁLVARO AVEZUM
NOVAS PERSPECTIVAS TERAPÊUTICAS EM DOENÇAS CARDIOMETABÓLICAS - ATUALIZAÇÃO BASEADAS EM EVIDÊNCIAS - FREDERICO TOLEDO CAMPO DALL’ORTO e HENRIQUE PATRUS MUNDIM PENA
| Artigo | Autor(es) | Referência |
|---|---|---|
| 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. | Sem autores | Diabetes care. 2024 Jan; 47(Jan):S179-S218. doi: 10.2337/dc24-S010. pii: . |
| 2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure: A Report of the American College of Cardiology. | Kittleson Michelle M, Benjamin Emelia J, Blumer Vanessa, Harrington Josephine, Januzzi James L, McMurray John J V, Vest Amanda R | Journal of the American College of Cardiology. 2025 Nov; 86(Nov):1953-1975. doi: 10.1016/j.jacc.2025.05.008. pii: S0735-1097(25)06481-2. |
| 2025 Brazilian Evidence-based Guideline on the Management of Obesity and Prevention of Cardiovascular Disease and Obesity-Associated Complications: A Position Statement by Five Medical Societies. | Saraiva José Francisco Kerr, Valerio Cynthia M, Rached Fabiana H, Sande-Lee Simone Van de, Giraldez Viviane Z Rocha, Valente Fernando, Drager Luciano F, Halpern Bruno, Silva Junior Wellington S da, Trujilho Fabio R, Dornellas Neuton, Silva Filho Ruy Lyra da, Salles João Eduardo N, Assad Marcelo H V, Mancini Marcio C, Miranda Paulo A C, Moreira Rodrigo O, Lamounier Rodrigo N, Kaiser Sergio E, Bertoluci Marcello C | Arquivos brasileiros de cardiologia. 2025 Dec; 122(Dec):e20250621. doi: 10.36660/abc.20250621. pii: e20250621. |
| 2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies. | Valerio Cynthia M, Saraiva Jose F K, Valente Fernando, van de Sande-Lee Simone, Rocha Viviane Z, Rached Fabiana H, Drager Luciano F, Halpern Bruno, Júnior Wellington S Silva, Trujilho Fabio R, Dornelas Neuton, da Silva Filho Ruy Lyra, Salles João Eduardo N, Assad Marcelo H V, Mancini Marcio C, Miranda Paulo A C, Moreira Rodrigo, Lamounier Rodrigo N, Kaiser Sergio, Bertoluci Marcello C | Diabetology & metabolic syndrome. 2025 Nov; 17(Nov):432. doi: 10.1186/s13098-025-01954-8. pii: 432. |
| A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. | Ndumele Chiadi E, Neeland Ian J, Tuttle Katherine R, Chow Sheryl L, Mathew Roy O, Khan Sadiya S, Coresh Josef, Baker-Smith Carissa M, Carnethon Mercedes R, Després Jean-Pierre, Ho Jennifer E, Joseph Joshua J, Kernan Walter N, Khera Amit, Kosiborod Mikhail N, Lekavich Carolyn L, Lewis Eldrin F, Lo Kevin B, Ozkan Bige, Palaniappan Latha P, Patel Sonali S, Pencina Michael J, Powell-Wiley Tiffany M, Sperling Laurence S, Virani Salim S, Wright Jackson T, Rajgopal Singh Radhika, Elkind Mitchell S V, Rangaswami Janani, | Circulation. 2023 Nov; 148(Nov):1636-1664. doi: 10.1161/CIR.0000000000001186. pii: . |
| Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines. | Gourdy Pierre, Schiele François, Halimi Jean-Michel, Kownator Serge, Hadjadj Samy, Valensi Paul | Frontiers in cardiovascular medicine. 2023 ; 10():1227769. doi: 10.3389/fcvm.2023.1227769. pii: 1227769. |
| Cardio-Obesity and Therapeutic Advances: Intersections Between Excess Adiposity, Cardiovascular Risk, and Pharmacologic Interventions. | De Oliveira-Gomes Diana, de Majo Alfonso Martinez, Ardila-Delgado Angie, Inglis Sara S, Mandras Stacy A, Loro-Ferrer Juan F, daSilva-deAbreu Adrian | Current atherosclerosis reports. 2026 Feb; 28(Feb):21. doi: 10.1007/s11883-026-01395-2. pii: . |
| Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis. | An Xuedong, Sun WenJie, Wen Zhige, Duan LiYun, Zhang YueHong, Kang Xiaomin, Ji Hangyu, Sun Yuting, Jiang Linlin, Zhao Xuefei, Gao Qing, Lian Fengmei | Diabetes, obesity & metabolism. 2025 Apr; 27(Apr):1735-1751. doi: 10.1111/dom.16228. pii: . |
| Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. | Nicholls Stephen J, Bhatt Deepak L, Buse John B, Prato Stefano Del, Kahn Steven E, Lincoff A Michael, McGuire Darren K, Nauck Michael A, Nissen Steven E, Sattar Naveed, Zinman Bernard, Zoungas Sophia, Basile Jan, Bartee Amy, Miller Debra, Nishiyama Hiroshi, Pavo Imre, Weerakkody Govinda, Wiese Russell J, D'Alessio David, | American heart journal. 2024 Jan; 267(Jan):1-11. doi: 10.1016/j.ahj.2023.09.007. pii: S0002-8703(23)00280-6. |
| Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. | Joseph Joshua J, Deedwania Prakash, Acharya Tushar, Aguilar David, Bhatt Deepak L, Chyun Deborah A, Di Palo Katherine E, Golden Sherita H, Sperling Laurence S, | Circulation. 2022 Mar; 145(Mar):e722-e759. doi: 10.1161/CIR.0000000000001040. pii: . |
| Effect of bariatric surgery and pharmacological treatments on cardiovascular risk factors for adults with overweight and obesity: a systematic review and network meta-analysis. | Yang You, Cheng Xiaohong, Chen Siming, Xie Jiatong, Chen Gowen, Li Lifa, Feng Yue, Chen Yi, Liu Guanqun, Yin Yuan, Zhou Tong, Zhao Rui | International journal of surgery (London, England). 2026 Feb; 112(Feb):10446-64. doi: 10.1097/JS9.0000000000004566. pii: . |
| First study with positive cardiovascular outcome in obesity: Reflections on SELECT. | Pan Qi, Fei Sijia, Xie Ting, Guo Lixin | Aging medicine (Milton (N.S.W)). 2024 Jun; 7(Jun):272-275. doi: 10.1002/agm2.12300. pii: . |
| GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. | Sardà Helena, Genua Idoia, Miñambres Inka | Medicina clinica. 2025 Jul; 165(Jul):106951. doi: 10.1016/j.medcli.2025.106951. pii: S0025-7753(25)00177-0. |
| Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. | Nauck Michael A, Tuttle Katherine R, Tschöp Matthias H, Blüher Matthias | Lancet (London, England). 2026 Feb; 407(Feb):892-908. doi: 10.1016/S0140-6736(25)02105-1. pii: S0140-6736(25)02105-1. |
| Interventions for the prevention and management of cardiometabolic multiple long-term conditions. | Valabhji Jonathan, Hope David, Sayed Nuha El, Godia Pamela Miloya, Lawson Claire, Seidu Samuel, Khunti Kamlesh | Lancet (London, England). 2026 Jun; 407(Jun):2668-2684. doi: 10.1016/S0140-6736(26)00608-2. pii: S0140-6736(26)00608-2. |
| Managing Obesity in Individuals with Cardiovascular Disease: Are We Missing the Obvious? | Gao Miao, Singh Tanjot, Ajjan Ramzi A | European cardiology. 2026 ; 21():e17. doi: 10.15420/ecr.2025.53. pii: e17. |
| Oral Semaglutide: A Step Forward in Cardiovascular Risk Management for Type 2 Diabetes. | Luna-Ceron Eder, Kattamuri Lakshmi, Duvvuru Sparsha Reddy, Mukherjee Debabrata | Cardiovascular & hematological disorders drug targets. 2025 ; 25():227-230. doi: 10.2174/011871529X421551250801194823. pii: . |
| Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity. | Mares Adriana C, Chatterjee Saurav, Mukherjee Debabrata | Current opinion in cardiology. 2022 Jul; 37(Jul):350-355. doi: 10.1097/HCO.0000000000000955. pii: . |
| Type 2 diabetes and cardiovascular disease: risk reduction and early intervention. | Hinnen Debbie, Kruger Davida, Magwire Melissa | Postgraduate medicine. 2023 Jan; 135(Jan):2-12. doi: 10.1080/00325481.2022.2126235. pii: . |